Cargando…

Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease

BACKGROUND AND AIMS: Cystic Fibrosis associated liver disease (CFLD) develops in approximately 30% of CF patients. However, routine sensitive diagnostic tools for CFLD are lacking. Within this study, we aimed to identify new experimental biomarkers for the detection of CFLD. METHODS: 45 CF patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rath, Timo, Hage, Lisa, Kügler, Marion, Menendez Menendez, Katrin, Zachoval, Reinhart, Naehrlich, Lutz, Schulz, Richard, Roderfeld, Martin, Roeb, Elke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597583/ https://www.ncbi.nlm.nih.gov/pubmed/23516586 http://dx.doi.org/10.1371/journal.pone.0058955

Ejemplares similares

Identification of Neutrophil Activation Markers as Novel Surrogate Markers of CF Lung Disease
por: Rath, Timo, et al.
Publicado: (2014)

Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study
por: Klotter, Victoria, et al.
Publicado: (2017)

The Changing Face of Cystic Fibrosis and Its Implications for Screening
por: Naehrlich, Lutz
Publicado: (2020)

Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022)

Cathepsin L and B as Potential Markers for Liver Fibrosis: Insights From Patients and Experimental Models
por: Manchanda, Mansi, et al.
Publicado: (2017)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function
por: Düesberg, Uta, et al.
Publicado: (2020)

Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry
por: Hatziagorou, Elpis, et al.
Publicado: (2023)

Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case–control study
por: Bagheri-Hanson, Azadeh, et al.
Publicado: (2014)

Presence of intestinal Mycobacterium avium subspecies paratuberculosis (MAP) DNA is not associated with altered MMP expression in ulcerative colitis
por: Rath, Timo, et al.
Publicado: (2011)

Systemic and Mucosal Immune Reactivity upon Mycobacterium avium ssp. paratuberculosis Infection in Mice
por: Koc, Arzu, et al.
Publicado: (2014)

Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen
por: Brauer, Rena, et al.
Publicado: (2011)

Interleukin-13 (IL-13)—A Pleiotropic Cytokine Involved in Wound Healing and Fibrosis
por: Roeb, Elke
Publicado: (2023)

Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?
por: Niedermayr, Katharina, et al.
Publicado: (2022)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

Proteomics and Metabolomics for Cystic Fibrosis Research
por: Liessi, Nara, et al.
Publicado: (2020)

Genomic Methylation Inhibits Expression of Hepatitis B Virus Envelope Protein in Transgenic Mice: A Non-Infectious Mouse Model to Study Silencing of HBV Surface Antigen Genes
por: Graumann, Franziska, et al.
Publicado: (2015)

Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice
por: Hempel, Felix, et al.
Publicado: (2019)

Transient Elastography in the Evaluation of Cystic Fibrosis–Associated Liver Disease: Systematic Review and Meta-analysis
por: Lam, Simon, et al.
Publicado: (2019)

Does Schistosoma Mansoni Facilitate Carcinogenesis?
por: von Bülow, Verena, et al.
Publicado: (2021)

Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Isolation of Hepatocytes from Liver Tissue by a Novel, Semi-Automated Perfusion Technology
por: Poggel, Carsten, et al.
Publicado: (2022)

Mutant MMP-9 and HGF Gene Transfer Enhance Resolution of CCl(4)-Induced Liver Fibrosis in Rats: Role of ASH1 and EZH2 Methyltransferases Repression
por: Atta, Hussein, et al.
Publicado: (2014)

The cystic fibrosis lower airways microbial metagenome
por: Moran Losada, Patricia, et al.
Publicado: (2016)

Matrix metalloproteinase-13 refines pathological staging of precancerous colorectal lesions
por: Wernicke, Anna-Katharina, et al.
Publicado: (2016)

High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study
por: Scheuing, Nicole, et al.
Publicado: (2014)

Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis
por: Fidika, Astrid, et al.
Publicado: (2014)

C1q/TNF-Related Protein 3 (CTRP-3) Deficiency of Adipocytes Affects White Adipose Tissue Mass but Not Systemic CTRP-3 Concentrations
por: Schmid, Andreas, et al.
Publicado: (2021)

Changes in the lipid profile of hamster liver after Schistosoma mansoni infection, characterized by mass spectrometry imaging and LC–MS/MS analysis
por: Wiedemann, Katja R., et al.
Publicado: (2022)

Serum-Based Proteomics Profiling in Adult Patients with Cystic Fibrosis
por: Benabdelkamel, Hicham, et al.
Publicado: (2020)

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2022)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
por: Lee, Jung M., et al.
Publicado: (2012)

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2023)

Cannabinoid receptor 1 knockout alleviates hepatic steatosis by downregulating perilipin 2
por: Irungbam, Karuna, et al.
Publicado: (2019)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

Proteomic Analysis of Nasal Epithelial Cells from Cystic Fibrosis Patients
por: Jeanson, Ludovic, et al.
Publicado: (2014)

A Proteomic Survey of the Cystic Fibrosis Transmembrane Conductance Regulator Surfaceome
por: Iazzi, Melissa, et al.
Publicado: (2023)

Targeting Kinases in Fasciola hepatica: Anthelminthic Effects and Tissue Distribution of Selected Kinase Inhibitors
por: Morawietz, Carolin M., et al.
Publicado: (2020)

Hepatocyte integrity depends on c-Jun-controlled proliferation in Schistosoma mansoni infected mice
por: Härle, Lukas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kem95pi06m5j9k1729hosbjd6n